Skip to content
Screener

EBIT at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$13.29M-88.5%
United Therapeutics logo
United TherapeuticsUTHR
$330.8M-9.2%
Solid Biosciences Inc. logo
Solid Biosciences Inc.SLDB
-$57.38M-37.6%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$40.46M+191%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$1.29B+19.8%
Savara logo
SavaraSVRA
-$38.99M-37.1%

Other financials

Income statement

See full
Revenue$425.5M+296%
Gross profit$358.3M+352%
Operating income-$1.5M+99.5%
Net income-$13.2M+95.9%
EPS (diluted)-$0.06+96.5%

Balance sheet

See full
Cash & equivalents$544.8M-57.6%
Total debt$579.9M+0.8%
Total equity$757.5M-39.4%
Total assets$2.1B-15.2%

Cash flow

See full
Operating cash flow-$88.8M+56.8%
CapEx$6.3M+79.6%
Free cash flow-$95.1M+54.5%

Valuation

See full
Market cap$21.46B+1.6%
Enterprise value$21.5B+5.3%
P/S18.9×-34.2×

Profitability

See full
Gross margin83.5%+7.7pp
Operating margin-73.9%-30.6pp
Net margin-76.9%-31.8pp
FCF margin-71%-28.6pp

Returns & leverage

See full
Return on equity-87.2%-27.3pp
Debt / equity0.8×+0.3×
Current ratio3.7×-3.0×

Where this comes from

Calculated from Insmed’s reported figures.

The source filing: Insmed’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 6:59 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001104506-26-000041

FAQ

What is Insmed's EBIT?
Insmed (INSM) reported EBIT of -$1.55M in Q2 2026.
How has Insmed's EBIT changed year-over-year?
Insmed's EBIT increased by 99.5% year-over-year, from -$312.88M to -$1.55M.
What is the long-term trend for Insmed's EBIT?
Over 4 years (2021 to 2025), Insmed's EBIT has grown at a 35.0% compound annual growth rate (CAGR), from -$375.09M to -$1.25B.
What does EBIT mean?
Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.

Ask your AI about Insmed's ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude